All Stories

  1. Using a life table to quantify survival-related selection bias in studies of racial health disparities
  2. Improvement and disparities in sustained viral suppression among people with HIV in New York City, 2014–2023
  3. Recommendation on the use of viral load tests and exclusion of CD4 tests as proxies for HIV medical visits
  4. Social determinants of health analysis makes causal inference and requires analytic epidemiology methods
  5. Impact of HIV preexposure prophylaxis prescriptions on HIV diagnoses in New York City
  6. The case for retiring ‘period prevalence’
  7. Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015–2022
  8. Improvement in CD4+ cell count among people with HIV in New York City, 2007–2021
  9. Homelessness and housing assistance among persons with HIV, and associations with HIV care and viral suppression, New York City 2018
  10. Life Expectancy Among People With HIV in New York City, 2009–2018
  11. Improving HIV preexposure prophylaxis implementation within healthcare settings
  12. Years Since Diagnosis Among People Living With Diagnosed HIV in New York City
  13. Calculating Age-Standardized Death Rates Among People With HIV Comparable Across Jurisdictions and Over Time
  14. The usefulness of HIV partner services in the age of treatment as prevention: a registry-based study
  15. Estimating the probability of diagnosis within 1 year of HIV acquisition
  16. Use of molecular HIV surveillance data and predictive modeling to prioritize persons for transmission-reduction interventions
  17. Use of Median Age at Death to Assess HIV mortality
  18. New York City HIV Care Continuum Dashboards: Using Surveillance Data to Improve HIV Care Among People Living With HIV in New York City
  19. An expanded HIV screening strategy in the Emergency Department fails to identify most patients with undiagnosed infection: insights from a blinded serosurvey
  20. Reduction in Gaps in High CD4 Count and Viral Suppression Between Transgender and Cisgender Persons Living With HIV in New York City, 2007–2016
  21. Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis
  22. Transition from paediatric to adult care among persons with perinatal HIV infection in New York City, 2006–2015
  23. Potential Misclassification of HIV-Positive Persons As Transgender Men
  24. Redefining Prevention and Care: A Status-Neutral Approach to HIV
  25. Undiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015
  26. Persons living with diagnosed HIV in New York City: over 50% over 50 years old
  27. Should we report the proportion of late HIV diagnoses?
  28. Using the Revised Centers for Disease Control and Prevention Staging System to Classify Persons Living With Human Immunodeficiency Virus in New York City, 2011–2015
  29. Linkage to Care After HIV Diagnosis in New York City
  30. Brief Report
  31. Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City
  32. Hospitalization Rates Among People With HIV/AIDS in New York City, 2013
  33. Estimated HIV Incidence in the United States, 2003–2010
  34. New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks
  35. Constructing a representative sample of out-of-care HIV patients from a representative sample of in-care patients
  36. Continuum of Care Among People Living with Perinatally Acquired HIV Infection in New York City, 2014
  37. The Association between Neighborhood Poverty and HIV Diagnoses among Males and Females in New York City, 2010–2011
  38. Persons Living with HIV in the United States
  39. Implementation and Operational Research
  40. Comparison of Single-Visit and Multiple-Visit Measures of Retention in Care for HIV Monitoring and Evaluation
  41. Persistent Racial Disparities in HIV Infection in the USA: HIV Prevalence Matters
  42. Comparison of indicators measuring the proportion of human immunodeficiency virus–infected persons with a suppressed viral load
  43. Proportions of Patients With HIV Retained in Care and Virally Suppressed in New York City and the United States
  44. A Run-in Period Is Needed in Randomized Controlled Trials of Directly Observed Antiretroviral Therapy for HIV Infection
  45. Monitoring Outcomes for Newly Diagnosed and Prevalent HIV Cases Using a Care Continuum Created With New York City Surveillance Data
  46. Limitations of Indicators of HIV Case Finding
  47. The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model
  48. Retention in Care and Viral Suppression Among Persons Living With HIV/AIDS in New York City, 2006–2010
  49. The Effect of Case Rate and Coinfection Rate on the Positive Predictive Value of a Registry Data-Matching Algorithm
  50. Sexually Transmitted Diseases Among Persons With HIV With Low Viral Load
  51. Achievement and Maintenance of Viral Suppression in Persons Newly Diagnosed With HIV, New York City, 2006–2009
  52. Revisiting the Methodology of Measuring HIV Community Viral Load
  53. To Weight or Not to Weight in Time-location Sampling: Why Not Do Both?
  54. Tuberculosis and HIV Co-infection, California, USA, 1993–2008
  55. Recent Decline in the Incidence of Human Immunodeficiency Virus Infection Among California Men Who Have Sex With Men
  56. Matching AIDS and tuberculosis registry data to identify AIDS/tuberculosis comorbidity cases in California
  57. Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
  58. Discordance between Sexual Behavior and Self-Reported Sexual Identity
  59. Knowledge of sexual partnerʼs HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men
  60. The Effect of Venue Sampling on Estimates of HIV Prevalence and Sexual Risk Behaviors in Men Who Have Sex With Men
  61. HIV Prevalence and Sexual Risk Behaviors Among Men Who Have Sex With Men
  62. High Prevalence of Sexually Transmitted Diseases Among Men Who Have Sex With Men in Jiangsu Province, China
  63. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: A meta-analysis of literature